On Tuesday, Automatic Data Processing (NASDAQ:ADP)’s shares declined -0.01% to $84.69.
ADP(R) (ADP), a leading global provider of Human Capital Administration (HCM) solutions, recently declared its fourth quarter and fiscal 2015 financial results and offered an initial outlook for fiscal 2016.
For the quarter, revenues from ongoing operations grew 5% to $2.7 billion and were negatively influenced three percentage points by unfavorable foreign currency translation. Pretax earnings grew 7% to $382 million and were negatively influenced two percentage points by unfavorable foreign currency translation. Pretax margin expanded 30 basis points in the quarter to 14.2%, which comprised of a negative impact of about 20 basis points from the client funds extended investment strategy. Diluted earnings per share from ongoing operations raised 15% to $0.55 on a lower effective tax rate and fewer shares outstanding contrast with last year’s fourth quarter, and comprised of higher-than-anticipated selling expenses resulting from exceptionally strong new business bookings that exceeded internal expectations.
Automatic Data Processing, Inc., together with its auxiliaries, provides technology-based outsourcing solutions to employers worldwide. The company operates through Employer Services and Professional Employer Organization (PEO) Services segments. The Employer Services segment offers a range of business outsourcing and human capital administration (HCM) solutions, counting payroll services, benefits administration services, talent administration solutions, human resources administration solutions, time and attendance administration solutions, insurance services, retirement services, and tax compliance and payment solutions.
Inteliquent Inc (NASDAQ:IQNT)’s shares gained 19.96% to $21.40.
Inteliquent, Inc. (IQNT), a leading provider of voice services, declared that its Board of Directors has declared a quarterly dividend of $0.15 per outstanding share of common stock. The quarterly dividend will be paid on September 7, 2015 to stockholders of record as of the close of business on August 24, 2015.
Inteliquent, Inc. provides voice telecommunications services on a wholesale basis in the United States and internationally. The company offers its services using an all-IP network, which enables to deliver global connectivity for various media, counting voice. It provides voice services comprising local transit, long distance, switched access, international voice, direct inward dialing, and toll-free services.
At the end of Tuesday’s trade, Celgene Corporation (NASDAQ:CELG)‘s shares dipped -0.77% to $130.20.
Celgene Corporation (CELG) declared that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) with respect to the formerly declared tender offer by its wholly-owned partner, Strix Corporation, for all issued and outstanding shares of common stock of Receptos, Inc. (RCPT) at a price of $232.00 per share, net to the seller in cash, without interest and less required withholding taxes and subsequent merger of Strix Corporation with Receptos expired at 11:59 p.m. EDT on August 10, 2015. The expiration of the HSR waiting period satisfies one of the conditions to the closing of the pending acquisition, which remains subject to other customary closing conditions. Celgene anticipates the transaction to close in the third quarter of 2015.
The tender offer is planned to expire at midnight EDT on Monday, August 24, 2015, unless extended.
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, in addition to acute myeloid leukemia (AML).
Phillips 66 (NYSE:PSX), ended its Tuesday’s trading session with 0.22% gain, and closed at $83.24.
Phillips 66 (PSX) Chairman and CEO Greg Garland will speak to investors and securities analysts at the 2015 Barclays CEO Energy-Power Conference in New York on Wednesday, Sept. 9, at 10:25 a.m. EDT. Garland will talk about the company’s execution of its value-creating strategy, counting an update on growth projects, return enhancement opportunities and commitment to disciplined capital allocation.
Phillips 66 operates as an energy manufacturing and logistics company. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks to its refineries and other locations; and delivers refined and specialty products, in addition to provides storage services for crude oil and petroleum products. This segment also gathers, processes, transports, and markets natural gas; and transports, fractionates, and markets natural gas liquids in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
